Keywords
coronavirus disease (COVID‑19), thrombosis, anticoagulant therapy.
How to Cite
Zaremba, Y., Zaremba, O., Rak, N., Burmay, S., Vus, N., Goryn, V., Matsura, L., Nartova, A., PetrushkаS., & Soya, V. (2021). Thromboembolic complications of coronavirus disease (clinical case). The Practitioner, (3), 7-10. Retrieved from https://plr.com.ua/index.php/journal/article/view/648
Abstract
The article describes a clinical case of a complicated course of coronavirus disease (COVID‑19) in the form of
thromboembolic complications on the background of anticoagulant therapy.
References
1. Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID‑19 Infection: A Case Report and Review of the Literature. Rosen MH, Axelrad J, Hudesman D, Rubin DT, Chang S. Inflamm Bowel Dis. 2020 Jun 18;26(7):971-973. doi: 10.1093/ibd/izaa109.
2. Severe Clostridium difficile colitis as potential late complication associated with COVID‑19. Páramo-Zunzunegui J, Ortega-Fernández I, Calvo-Espino P, Diego-Hernández C, Ariza-Ibarra I, Otazu-Canals L, Danés-Grases JE, Menchero-Sánchez A. Ann R Coll Surg Engl. 2020 Sep;102(7): e176-e179. doi: 10.1308/rcsann.2020.0166. Epub 2020 Aug 17.
3. Are Patients with Inflammatory Bowel Disease at Increased Risk for COVID‑19 Infection? Monteleone G, Ardizzone S. J Crohns Colitis. 2020 Sep 16;14(9):1334-1336. doi: 10.1093/ecco-jcc/jjaa061.
4. SARS-CoV‑2 Gastrointestinal Infection Causing Hemorrhagic Colitis: Implications for Detection and Transmission of COVID‑19 Disease. Carvalho A, Alqusairi R, Adams A, Paul M, Kothari N, Peters S, DeBenedet AT. Am J Gastroenterol. 2020 Jun;115(6):942-946. doi: 10.14309/ajg.0000000000000667.
5. The many faces of the anti-COVID immune response. Vardhana SA, Wolchok JD. J Exp Med. 2020 Jun 1;217(6): e20200678. doi: 10.1084/jem.20200678.
6. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID‑19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry. Brenner EJ, Ungaro RC, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Ruemmele FM, Steinwurz F, Underwood FE, Zhang X, Colombel JF, Kappelman MD. Gastroenterology. 2020 Aug;159(2):481-491.e3. doi: 10.1053/j.gastro.2020.05.032. Epub 2020 May 18.
7. A fatal case of COVID‑19 pneumonia occurring in a patient with severe acute ulcerative colitis. Mazza S, Sorce A, Peyvandi F, Vecchi M, Caprioli F. Gut. 2020 Jun;69(6):1148-1149. doi: 10.1136/gutjnl‑2020-321183. Epub 2020 Apr 3.
8. Coronavirus disease 2019 (COVID‑19) and ischemic colitis: An under-recognized complication. Chan KH, Lim SL, Damati A, Maruboyina SP, Bondili L, Abu Hanoud A, Slim J. Am J Emerg Med. 2020 Dec;38(12):2758.e1-2758.e4. doi: 10.1016/j.ajem.2020.05.072. Epub 2020 May 27.
9. COVID‑19 associated Kawasaki-like multisystem inflammatory disease in an adult. Sokolovsky S, Soni P, Hoffman T, Kahn P, Scheers-Masters J. Am J Emerg Med. 2021 Jan; 39:253.e1-253.e2. doi: 10.1016/j.ajem.2020.06.053. Epub 2020 Jun 25.
10. COVID‑19 in patients with inflammatory bowel disease. Anikhindi SA, Kumar A, Arora A. Expert Rev Gastroenterol Hepatol. 2020 Dec;14(12):1187-1193. doi: 10.1080/17474124.2020.1816822.
2. Severe Clostridium difficile colitis as potential late complication associated with COVID‑19. Páramo-Zunzunegui J, Ortega-Fernández I, Calvo-Espino P, Diego-Hernández C, Ariza-Ibarra I, Otazu-Canals L, Danés-Grases JE, Menchero-Sánchez A. Ann R Coll Surg Engl. 2020 Sep;102(7): e176-e179. doi: 10.1308/rcsann.2020.0166. Epub 2020 Aug 17.
3. Are Patients with Inflammatory Bowel Disease at Increased Risk for COVID‑19 Infection? Monteleone G, Ardizzone S. J Crohns Colitis. 2020 Sep 16;14(9):1334-1336. doi: 10.1093/ecco-jcc/jjaa061.
4. SARS-CoV‑2 Gastrointestinal Infection Causing Hemorrhagic Colitis: Implications for Detection and Transmission of COVID‑19 Disease. Carvalho A, Alqusairi R, Adams A, Paul M, Kothari N, Peters S, DeBenedet AT. Am J Gastroenterol. 2020 Jun;115(6):942-946. doi: 10.14309/ajg.0000000000000667.
5. The many faces of the anti-COVID immune response. Vardhana SA, Wolchok JD. J Exp Med. 2020 Jun 1;217(6): e20200678. doi: 10.1084/jem.20200678.
6. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID‑19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry. Brenner EJ, Ungaro RC, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Ruemmele FM, Steinwurz F, Underwood FE, Zhang X, Colombel JF, Kappelman MD. Gastroenterology. 2020 Aug;159(2):481-491.e3. doi: 10.1053/j.gastro.2020.05.032. Epub 2020 May 18.
7. A fatal case of COVID‑19 pneumonia occurring in a patient with severe acute ulcerative colitis. Mazza S, Sorce A, Peyvandi F, Vecchi M, Caprioli F. Gut. 2020 Jun;69(6):1148-1149. doi: 10.1136/gutjnl‑2020-321183. Epub 2020 Apr 3.
8. Coronavirus disease 2019 (COVID‑19) and ischemic colitis: An under-recognized complication. Chan KH, Lim SL, Damati A, Maruboyina SP, Bondili L, Abu Hanoud A, Slim J. Am J Emerg Med. 2020 Dec;38(12):2758.e1-2758.e4. doi: 10.1016/j.ajem.2020.05.072. Epub 2020 May 27.
9. COVID‑19 associated Kawasaki-like multisystem inflammatory disease in an adult. Sokolovsky S, Soni P, Hoffman T, Kahn P, Scheers-Masters J. Am J Emerg Med. 2021 Jan; 39:253.e1-253.e2. doi: 10.1016/j.ajem.2020.06.053. Epub 2020 Jun 25.
10. COVID‑19 in patients with inflammatory bowel disease. Anikhindi SA, Kumar A, Arora A. Expert Rev Gastroenterol Hepatol. 2020 Dec;14(12):1187-1193. doi: 10.1080/17474124.2020.1816822.
Downloads
Download data is not yet available.